top of page

Mathai Mammen on being back to company building at Fog Pharma

He describes how Fog is leveraging the way α-helices mediate interactions with other proteins as an approach to solve the problem of most structures being undruggable.



Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page